Document Detail


In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells.
MedLine Citation:
PMID:  15599309     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Microencapsulation is under consideration as a means of enabling pancreatic islet transplantation. To understand better the ongoing destructive host response, we examined whether the adaptive immune system of the recipient recognized polymer-encapsulated xenogeneic cells implanted intraperitoneally. METHODS: Balb/c mice were implanted with xenogeneic Chinese hamster ovary cells, inside and outside poly(hydroxyethyl methacrylate-methyl methacrylate) microcapsules, and responses were compared with xenografted Chinese hamster skin (positive control). Capsules were localized within an agarose rod. Splenocyte proliferation upon rechallenge in vitro, antibody titer in serum, and Th1/2 polarization (assessed by interleukin-4 and interferon-gamma in supernatants of antigen-challenged splenocytes and immunoglobulin [Ig]G1 and IgG2a antibody isotypes in serum) were measured. RESULTS: Encapsulation did not prevent a strong recipient antibody response. Splenocyte proliferation in vitro did not differ after priming by implanted cells, inside or outside capsules. Thus, the capsule membrane did not prevent indirect recognition of shed antigens. However, after 10 days of implantation, proliferation was lower than that induced by skin grafts, although this difference disappeared by 2 months. This transient T-cell suppression was unexpected because encapsulated cell viability was already compromised by 10 days. The influence of Th1/2 bias did not explain the observed suppression. Cells inside capsules elicited a consistent Th2 response, whereas cells outside capsules elicited a mixed response, and skin xenografts showed an initial Th2 response that became mixed by 2 months. CONCLUSIONS: Encapsulation does not prevent host immune responses, but the inflammatory response to the implanted biomaterials or xenogeneic cells may be responsible both for encapsulated cell death and transient T-cell suppression.
Authors:
Kim S Jones; Michael V Sefton; Reginald M Gorczynski
Related Documents :
12054019 - Dimethicone barrier cream prevents infection of human skin by schistosome cercariae: ev...
2203659 - Psoriasis related to angiotensin-converting enzyme inhibitors.
1419749 - Distribution of interleukin 1 receptor antagonist protein (irap), interleukin 1 recepto...
20100199 - Chemokine expression by human keratinocyte cell lines after activation of toll-like rec...
8381839 - Influence of inflammatory mediators and cytokines on human melanocyte function.
2206969 - Skin exudate levels of interleukin 6, interleukin 1 and other cytokines in mycosis fung...
8061119 - Interleukin-4 enhances murine bone marrow macrophage m-csf receptor expression by a pos...
15816839 - 4-tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediate...
10090189 - Pathogenesis of joint damage in rheumatoid arthritis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Transplantation     Volume:  78     ISSN:  0041-1337     ISO Abbreviation:  Transplantation     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-12-15     Completed Date:  2005-04-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1454-62     Citation Subset:  IM    
Affiliation:
Department of Chemical Engineering and Applied Chemistry, and Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada. kjones@mcmaster.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
CHO Cells
Capsules
Cricetinae
Cricetulus
Female
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Ovary / transplantation
Skin Transplantation / immunology*,  methods
Spleen / immunology*
Transplantation, Heterologous / immunology*,  methods
Chemical
Reg. No./Substance:
0/Capsules

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in p...
Next Document:  Gene therapy-mediated CD40L and CD28 co-stimulatory signaling blockade plus transient anti-xenograft...